Skip to content

Spanish BMT4me Usability & Acceptability

Spanish BMT4me Usability & Acceptability

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06361173
Enrollment
30
Registered
2024-04-11
Start date
2024-10-09
Completion date
2025-09-24
Last updated
2025-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Marrow Transplant

Brief summary

The objective of this project is to trans-create, conduct user testing of a previously developed and piloted mHealth app, and user acceptability with parents of children in the acute phase post-allogeneic hematopoietic stem cell transplant (HSCT). Nationwide Children's Hospital (NCH) will be the primary data collection site and Columbia University Irving Medical Center will be a secondary site.

Interventions

OTHERBMT4me

Caregivers will pilot test a Spanish version of the BMT4me app at a single time point.

Sponsors

Columbia University
CollaboratorOTHER
Nationwide Children's Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
0 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

Eligible caregivers must have children who: 1. Are 0-17 years old 2. Underwent HCT 3. Are planned for discharge prior to day 100 post-transplant Primary caregivers must: 1. Be Spanish speaking 2. Be ≥18 years old 3. Have a smartphone (iOS or Android) capable of downloading apps

Exclusion criteria

(a) Children or caregivers with pre-existing neurodevelopmental disorder/disability or a pervasive developmental disorder will be excluded from this study.

Design outcomes

Primary

MeasureTime frameDescription
Assess app usability using the System Usability Scale (SUS)6/1/24 - 5/1/26Data collected using the System Usability Scale (SUS) will provide insight to the usability of the Spanish BMT4Me app in its current form. he SUS is a 10-item questionnaire routinely used to evaluate the functionality and acceptability of mHealth apps. The SUS is scored on a scale, giving a score from from 0 to 100 where 100 is considered the highest rating of usability. A score of \> 68 is considered above average.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026